KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 97 filers reported holding KRONOS BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71 | -85.6% | 54,521 | -80.9% | 0.01% | -87.8% |
Q2 2023 | $492 | -17.0% | 286,165 | -29.6% | 0.05% | -16.9% |
Q1 2023 | $593 | -16.8% | 406,362 | -7.6% | 0.06% | -33.0% |
Q4 2022 | $713 | -99.9% | 439,926 | +186.2% | 0.09% | +29.4% |
Q3 2022 | $515,000 | +63.0% | 153,691 | +77.0% | 0.07% | +44.7% |
Q2 2022 | $316,000 | +0.3% | 86,846 | +99.4% | 0.05% | +11.9% |
Q1 2022 | $315,000 | – | 43,562 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |